MicroRNA-30d and -483-3p for Bi-Ventricular Remodelling and miR-126-3p for Pulmonary Hypertension in Advanced Heart Failure
ESC Heart Failure · 2024
DOI: 10.1002/ehf2.14546 ↗Kurz gefasst
Fachartikel in der Zeitschrift ESC Heart Failure, 2024. Verfasst von Alessia Gallo und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Research, IRCCS-ISMETT, Palermo, Italy. Hauptthemen laut MEDLINE: Cardiomyopathies, Heart Failure, Hypertension, Pulmonary, MicroRNAs. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Ministero della Salute.
Themen: Herzinsuffizienz
Abstract (Originalsprache)
Aims
MicroRNAs play a role in pathogenic mechanisms leading to heart failure. We measured a panel of 754 miRNAs in the myocardial tissue and in the serum of patients with heart failure with reduced ejection fraction due to dilatative idiopathic cardiomyopathy (DCM, N = 10) or ischaemic cardiomyopathy (N = 3), referred to left ventricular assist device implant. We aim to identify circulating miRNAs with high tissue co-expression, significantly associated to echocardiographic and haemodynamic measures. Methods and results We have measured a panel of 754 miRNAs in the myocardial tissue [left ventricular (LV) apex] and in the serum obtained at the same time in a well selected study population of end-stage heart failure with reduced ejection fraction due to either DCM or ischaemic cardiomyopathy, referred to continuous flow left ventricular assist device implant. We observed moderate agreement for miR-30d, miR-126-3p, and miR-483-3p. MiR-30d was correlated to LV systolic as well as diastolic volumes (r = 0.78, P = 0.001 and r = 0.80, P = 0.005, respectively), while miR-126-3p was associated to mPAP and PCWP (r = −0.79, P = 0.007 and r = −0.80, P = 0.005, respectively). Finally, serum miR-483-3p had an association with right ventricular end diastolic diameter (r = −0.73, P = 0.02) and central venous pressure (CVP) (r − 0.68 p 0.03).
Conclusions
In patients with DCM, few miRNAs are co-expressed in serum and tissue: They are related to LV remodelling (miR-30d), post-capillary pulmonary artery pressure (miR-126-3p), and right ventricular remodelling/filling pressures (miR-483-3p). Further studies are needed to confirm their role in diagnosis, prognosis or as therapeutic targets in heart failure with reduced ejection fraction.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Research, IRCCS-ISMETT, Palermo, Italy.
- Department for the Treatment and Study of Cardiothoracic Diseases and Cardiothoracic Transplantation, IRCCS-ISMETT, Palermo, Italy.
- Department of Internal Medicine, Division of Cardiovascular Diseases, Mayo Clinic and Foundation, Rochester, MN, USA.
Förderung
- Ministero della Salute
Zitieren
APA
Gallo, A., Agnese, V., Sciacca, S., Scardulla, C., Cipriani, M., Pilato, M., Oh, J. K., Pasta, S., Maalouf, J., Conaldi, P. G., & Bellavia, D. (2024). MicroRNA-30d and -483-3p for Bi-Ventricular Remodelling and miR-126-3p for Pulmonary Hypertension in Advanced Heart Failure. ESC Heart Failure. https://doi.org/10.1002/ehf2.14546
Vancouver
Gallo A, Agnese V, Sciacca S, Scardulla C, Cipriani M, Pilato M, et al. MicroRNA-30d and -483-3p for Bi-Ventricular Remodelling and miR-126-3p for Pulmonary Hypertension in Advanced Heart Failure. ESC Heart Failure. 2024. doi:10.1002/ehf2.14546
BibTeX
@article{Gallo2024,
author = {Gallo, Alessia and Agnese, Valentina and Sciacca, Sergio and Scardulla, Cesare and Cipriani, Manlio and Pilato, Michele and Oh, Jae K and Pasta, Salvatore and Maalouf, Joseph and Conaldi, Pier Giulio and Bellavia, Diego},
title = {MicroRNA-30d and -483-3p for Bi-Ventricular Remodelling and miR-126-3p for Pulmonary Hypertension in Advanced Heart Failure},
journal = {ESC Heart Failure},
year = {2024},
doi = {10.1002/ehf2.14546}
}
EUVIMED